Stay updated with breaking news from Next Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Guardant Health, Inc. (NASDAQ:GH – Get Free Report) insider Kumud Kalia sold 5,800 shares of the company’s stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $26.37, for a total value of $152,946.00. Following the completion of the transaction, the insider now directly owns 5,926 […]
BioAffinity Technologies (NASDAQ:BIAF – Get Free Report) and Guardant Health (NASDAQ:GH – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership and risk. Institutional & Insider Ownership 1.1% of bioAffinity Technologies […]
Guardant Health, Inc. (NASDAQ:GH – Get Free Report) has received an average rating of “Buy” from the fifteen ratings firms that are presently covering the stock, Marketbeat.com reports. Fifteen investment analysts have rated the stock with a buy rating. The average 12 month price objective among brokerages that have covered the stock in the last […]
Guardant Health, Inc. (NASDAQ:GH – Get Free Report) has been assigned an average rating of “Buy” from the fifteen ratings firms that are presently covering the stock, Marketbeat.com reports. Fifteen analysts have rated the stock with a buy rating. The average 1-year target price among brokerages that have updated their coverage on the stock in […]
Guardant Health (NASDAQ:GH – Get Free Report) was upgraded by investment analysts at Raymond James from a “market perform” rating to an “outperform” rating in a research note issued to investors on Monday, Marketbeat reports. The firm currently has a $27.00 price objective on the stock. Raymond James’ price target would suggest a potential upside […]